This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Meta-Analysis

. 1992 Jan 11;304(6819):119.

doi: 10.1136/bmj.304.6819.119-a.

Chemotherapy in advanced ovarian cancer

L A Stewart, D Guthrie, M K Parmar, C J Williams

PMID: 1531311
PMCID: PMC1881025
DOI: 10.1136/bmj.304.6819.119-a

Meta-Analysis

Chemotherapy in advanced ovarian cancer

L A Stewart et al. BMJ. 1992.

. 1992 Jan 11;304(6819):119.

doi: 10.1136/bmj.304.6819.119-a.

Authors

L A Stewart, D Guthrie, M K Parmar, C J Williams

PMID: 1531311
PMCID: PMC1881025
DOI: 10.1136/bmj.304.6819.119-a

No abstract available

PubMed Disclaimer

Comment on

Chemotherapy in advanced ovarian cancer.
Cruickshank DJ. Cruickshank DJ. BMJ. 1991 Nov 16;303(6812):1269. doi: 10.1136/bmj.303.6812.1269-a. BMJ. 1991. PMID: 1747658 Free PMC article. No abstract available.

Similar articles

Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer.
Markman M. Markman M. Gynecol Oncol. 2007 Jul;106(1):273-4; author reply 274-5. doi: 10.1016/j.ygyno.2007.03.013. Epub 2007 Apr 30. Gynecol Oncol. 2007. PMID: 17467780 No abstract available.
Dose intensity in advanced ovarian cancer: have we answered the question?
Fennelly D. Fennelly D. Clin Cancer Res. 1995 Jun;1(6):575-82. Clin Cancer Res. 1995. PMID: 9816018 Review. No abstract available.
[Combination chemotherapy with docetaxel and carboplatin for epithelial ovarian cancer].
Misawa H, Ochiai K, Yasuda M, Tanaka T. Misawa H, et al. Nihon Rinsho. 2004 Oct;62 Suppl 10:546-9. Nihon Rinsho. 2004. PMID: 15535305 Review. Japanese. No abstract available.
Chemotherapy for ovarian cancer: beyond paclitaxel plus carboplatin.
Ozols RF. Ozols RF. Cancer J Sci Am. 1999 Nov-Dec;5(6):336-8. Cancer J Sci Am. 1999. PMID: 10606473 No abstract available.
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
[No authors listed] [No authors listed] BMJ. 1991 Oct 12;303(6807):884-93. doi: 10.1136/bmj.303.6807.884. BMJ. 1991. PMID: 1834291 Free PMC article.

See all similar articles

Cited by

Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
Lu H, Liu Y, Wang D, Wang L, Zhou H, Xu G, Xie L, Wu M, Lin Z, Yu Y, Li G. Lu H, et al. Tumour Biol. 2016 Aug;37(8):11469-77. doi: 10.1007/s13277-016-5004-3. Epub 2016 Mar 24. Tumour Biol. 2016. PMID: 27012551

References

1. BMJ. 1991 Nov 16;303(6812):1269 - PubMed
1. BMJ. 1990 Jun 2;300(6737):1458-60 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information